NovellusDx's Series B Round

NovellusDx raised a round of funding on December 24, 2015.

NovellusDx is a precision oncology company that has developed a live-cell based assay to monitor the activity of signaling pathways. Using this platform, NovellusDx' solution helps biopharma companies…

Articles about NovellusDx's Series B Round: